2023-509929-51-00
CTIS ↗
Single and multiple ascending dose of ZP9830 in healthy participants
Autoimmune diseases
pharma · Weight management · Short Bowel Syndrome
Zealand Pharma
Zealand Pharma A/S
Zealand Pharma trial registry — 18 ClinicalTrials.gov studies with program phase, status, and indication context.
Sydmarken 11, Søborg (Copenhagen), 2860, DK HQ
1998 Founded
596 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Sydmarken 11, Søborg (Copenhagen), 2860, DK
- Founded
- 1998
- Employees
- 596
- Programs
- 18
- Drugs
- 20
- Patents
- 0
Zealand Pharma clinical trials
Registry index of 18 ClinicalTrials.gov studies linked to Zealand Pharma programs — each row shows trial ID, program name, phase, status, and indication.
Zealand Pharma trial registry — 18 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Zealand Pharma.
-
ZP8396-25077 — Phase 1
Clinical update -
ZP1848-23029 — Phase 3
Clinical update -
ZP8396-25041 — Phase 1
Clinical update -
ZP8396-24059 — Phase 1
Clinical update -
ZP8396-23094 — Phase 2
Clinical update -
ZP7570-24026 — Phase 1
Clinical update -
Vitamin C — Phase 2
Clinical update -
TARGET protocol EN 1.5 kcal/mL — Phase 3
Clinical update